Stefan Sleijfer

Address Erasmus MC-Daniel den Hoed Cancer Centre
Rotterdam
Country

Netherlands

Stefan Sleijfer

Stefan Sleijfer, MD, PhD, was born in Groningen, The Netherlands, where he studied Medicine at the State University and graduated in 1996. He achieved his PhD at the same university in 1997 with the thesis “Clinical and Laboratory Studies on Chemo-Resistance and Sensitivity and the Role of TNF”. He did the residency in Internal Medicine from 1998 to 2004 and from 2002 to 2004 the residency in Medical Oncology at the Erasmus University Medical Center, Rotterdam, The Netherlands.

At the Erasmus MC he has since been a staff member of the Department of Medical Oncology; since 2008 a research co-ordinator in Cancer Genomics and Proteonomics, Associate Professor of Medical Oncology and since 2009 Deputy Head of the Department of Medical Oncology.

Prof. Sleijfer is an active member of several scientific Societies, among which: the Steering Committee Center for Personalised Cancer Care (Consortium UMC Utrecht, NK/Avl, Erasmus MC), Member of the Dutch Cancer Society, Vice-Chairman Translational Research Advisory Committee (TRAC) of the EORTC. He is a Member of ASCO and ESMO and ESMO Faculty Member for Sarcoma.

Prof. Sleijfer has been involved in the scientific organisation of several conferences. As scientific Co-Chair of the 2011 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, San Francisco USA; Track Chair of the Section Drug Development for the joint ECCO 16-36 ESMO Multidisciplinary Cancer Congress, Stockholm Sweden and Member of the scientific advisory board International Symposium on Targeted Anticancer Therapies.

He is Editorial Board Member of the Journal of Clinical Oncology, Clinical Sarcoma Research, the European Journal of Cancer; referee of several journals among which Annals of Oncology, International Journal of Cancer and European Journal of Cancer.

His research topics focus on: Translational Oncology - Establishment of prognostic and predictive markers in solid malignancies in particular circulating tumour cells and circulating endothelial cells.

He has authored and co-authored over 100 publications and has given over 60 presentations.